European Pharma Days

Join Bruker for the annual European Pharma Meeting taking place on April 15th – 16th 2026 in Mannheim, Germany, organized by Bruker and TH Mannheim’s M²Aind industry consortium and CeMOS Research and Transfer Center.

Discover Innovation at the Forefront of Pharmaceutical Research

Join us for an inspiring two day in-person European Pharma Days event, bringing together leading experts from the pharmaceutical industry and academia. Experience how state of the art mass spectrometry and imaging technologies are accelerating progress in pharmaceutical and clinical research.

What to expect:

• Insightful talks highlighting how ESI  and MALDI based MS approaches and innovative imaging technologies drive innovation across drug discovery and clinical research.
• In depth presentations on biologics characterization, featuring Top Down and HDX MS strategies for elucidating structure and dynamics.
• Comprehensive coverage of omics workflows, including metabolomics, lipidomics, and proteomics (metaproteomics and glycoproteomics), demonstrating the analytical power of TIMS enabled in-depth research.
• Dedicated presentations on small molecule characterisation, including the capabilities of MSⁿ eXd for structural elucidation.
• Cutting edge MALDI Imaging (MSI) research, illustrating the remarkable breadth of this technology—from drug formulation and lipid mapping in tissue, to tumor research combining MSI with mid infrared tissue characterization, and advanced 3D cell culture models.

Network, Learn, and Connect

The event will take place in a safe, comfortable, and collaborative environment, offering ample time for networking and scientific exchange. Connect with speakers, peers, and technology partners during extended breaks and in the exhibition area.

Location:

MAFINEX Technologiezentrum
Julius-Hatry-Straße 1
68163 Mannheim, Germany

Participation is free of charge, but seats are limited.

TBD
Julia Chamot-Rooke, Ph.D., CNRS Senior Scientist, Mass Spectrometry for Biology (MSBio) Laboratory, Institut Pasteur, Paris, France

MALDI-MSI strategies to visualise elusive and low abundance lipid species: Endocannabinoids
Eduardo Maria Sommella, Ph.D., Associate Professor, Medicinal Chemistry, Department of Pharmacy, University of Salerno, Salerno, Italy

Use of timsTOF for Omics approaches
Frédéric M. Vaz, Ph.D., Head Core Facility Metabolomics, Associate Professor, Amsterdam UMC, Amsterdam, The Netherlands

Structural Architecture of the Human Dolichol Synthesis Machinery
Petr Man, Ph.D., Researcher, Institute of Microbiology of the Czech Academy of Sciences, Vestec, Czech Republic

Spatial Control of Immune Cell Activation by Lipid–Protein Signaling Networks
Daniel Engel, Ph.D., Professsor, Department of Immunodynamics, Medical Research Center, University Hospital Essen, Germany

Eludication of the blood-ascites-tissue axis and peritoneal metastasis in ovarian cancer by multimodal metabolomics
Christoph Trautwein, Ph.D., Director Core Facility Metabolomics, University of Tübingen Hospital/M3 Research Center, Tübingen, Germany

Small molecule structure elucidation by MS2/MS3 EID/CID on timsOMNI and building and using multiple AI models from timsTOF data - How to Train a Dragon
Gustaf Hulthe, Ph.D., Pharmaceutical Technology and Development, AstraZeneca, Gothenburg, Sweden

From Sample to Mixed Reality: A Translational 3D MALDI Imaging Platform for Analysis of 3D Cell Culture Disease Models
Stefania Alexandra Iakab, Postdoctoral Researcher, Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim, Germany

A Scalable Microbial Platform for CNS Therapeutic Discovery and Development
Jie Zhang, Ph.D., Co-Founder & CTO, Bioma Aps, Copenhagen, Denmark

TBD
Stefan Kempa, Ph.D., Group Leader Proteomics and Metabolomics, Max-Delbrück-Centrum für Molekulare Medizin (MDC), Berlin, Germany

MALDI Multiplexed spatial screening of lipid nanoparticles for in vivo mRNA targeting
Thomas Enzlein, Ph.D., Group Leader Bioinformatics, Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim, Germany

Investigating the effects of prebiotics on the gut microbiome using metaproteomics
Morten Danielsen, Ph.D., Global Metabolomics Lead, Cmbio, Copenhagen, Denmark

Integrating Spatial Transcriptomics and Mass Spectrometry Imaging to uncover gene-metabolite interactions across cell populations in pulmonary fibrosis
Achim Buck, Ph.D., Clin Pharm & Noncl Safety, Global Drug Metabolism and Pharmakokinetics, Boehringer Ingelheim Pharma GmbH, Biberach an der Riss, Germany

Spatial Control of Immune Cell Activation by Lipid–Protein Signaling Networks
Miriam Rittel, MSc., Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim, Germany

TBD
Julian Langer, Ph.D., Head of Mass Spectrometry, Max Planck Institute of Biophysics, Frankfurt, Germany

The detailed agenda will follow soon!